Upcoming Webinar: Resolving Target Biology and Compound MOA at Scale with BioGPU on April 22, 2026 Anima Biotech BioGPU biology (field) Compound MOA Target visual computing +
Sino Biological Launches SwiftFluo® TR-FRET Kinase Assay Kits for Advanced Drug Discovery on February 09, 2026 biology (field) Cyclin-Dependent Kinases high-throughput screening isononanoyl oxybenzene sulfonate Kinase Assay Kits Protein Tyrosine Kinase Serine/Threonine Kinases SwiftFluo TR-FRET +
GSK wins FDA approval for ultra-long-acting asthma drug Exdensur (depemokimab) on December 17, 2025 Approved Asthma biology (field) Depemokimab Exdensur Severe (severity modifier) SmithKline Beecham twice-yearly ultra-long acting United States Food and Drug Administration +
Despite Government Shutdown, Companies Still Plan to Submit FDA Applications on October 03, 2025 AbbVie Amgen Application procedure biology (field) drug applications funding lapse government J&J Myers Squibb Pfizer pharmaceutical delays shutdown United States Food and Drug Administration user fees +
Langers Team Launch $77.5M Fund to Invest at Intersection of Technology and Biology on September 19, 2025 biology (field) Capital Fund I Geographic Intersection Investments Michael Langer Robert Langer Technology venture capital +
Octagon Therapeutics Ceases Operations Due to R&D Challenges and Unresolved Biology Questions on April 29, 2025 Autoimmune Diseases B cell immunomodulator program biology (field) Flatulence Nordisk alliance OCT50 Programs - Publication Format +
Axplora Invests €50M in GLP-1 Manufacturing Expansion at Mourenx, France on February 13, 2025 alpha 1-antitrypsin Axplora biology (field) CDMO Chromatography Diabetes expansion France Glucagon-Like Peptide 1 manufacturing Mourenx Obesity production +